返回
Cardio Diagnostics Holdings Inc（CDIO）价格
CDIO 股价走势图
CDIO 收益
Cardio Diagnostics Holdings Inc
$1.81
2.84%
$0.05
收盘价：Jan 16, 16:00:00 GMT-5
$1.8
-0.55%
$-0.01
盘后：Jan 16, 20:00:00 GMT-5
关键数据
前收盘价
$1.76
开盘价
$1.71
当日区间
$1.71 - $1.87
52周范围
$1.64 - $21.15
交易量
85.6K
平均成交量
278.2K
每股收益（TTM）
-4.68
股息收益率
--
市值
$3.2M
什么是 CDIO？
Cardio Diagnostics Holdings, Inc. engages in the provision of medical diagnostic testing services. The company is headquartered in Chicago, Illinois and currently employs 13 full-time employees. The company went IPO on 2021-11-23. The firm develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.